Joji Tokita MD
Chronic Renal Failure & Dialysis, Renal Imaging
Associate Professor, Medicine, Icahn School of Medicine
Join to View Full Profile
1249 5th AvenueTerence Cardinal Cooke Health Care CenterNew York, NY 10029
Phone+1 212-360-3860
Fax+1 212-860-3860
Dr. Tokita is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount Sinai (Beth Israel)Fellowship, Nephrology, 2008 - 2010- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2004 - 2008
Rush Medical College of Rush University Medical CenterClass of 2004
University of ChicagoBA, 1995 - 1999
Certifications & Licensure
NY State Medical License 2007 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 1 citationsRationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis.Gabriel C Barsotti, Randy Luciano, Ashwani Kumar, Kristin Meliambro, Vijayakumar Kakade
Kidney International Reports. 2024-05-01 - 1 citationsA Real-World Precision Medicine Program Including the KidneyIntelX Test Effectively Changes Management Decisions and Outcomes for Patients With Early-Stage Diabetic Ki...Joji Tokita, David Lam, Aida Vega, Stephanie Wang, Leonard Amoruso
Journal of Primary Care & Community Health. 2024-01-08 - 3 citationsReal World Evidence and Clinical Utility of KidneyIntelX on Patients With Early-Stage Diabetic Kidney Disease: Interim Results on Decision Impact and Outcomes.Joji Tokita, Aida Vega, Catherine Sinfield, Nidhi Naik, Shivani Rathi
Journal of Primary Care & Community Health. 2022-11-21
Press Mentions
1,112 Patient Study Demonstrates Clinical Utility and Care Benefits of KidneyIntelX™ Risk Stratification in Stage 1 to 3 Diabetic Kidney Disease PatientsJune 20th, 2022- Renalytix and AEX Gold Among Early Risers on FridayJune 10th, 2022
New York Hospitals Face Another COVID-19 Equipment Shortage: Dialysis MachinesApril 16th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
